| AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ... Cancer cell 11 (1), 83-95, 2007 | 2075 | 2007 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The Lancet Oncology 18 (10), 1373-1385, 2017 | 946 | 2017 |
| A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study J Schuster, RK Lai, LD Recht, DA Reardon, NA Paleologos, MD Groves, ... Neuro-oncology 17 (6), 854-861, 2015 | 409 | 2015 |
| Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach R Rockne, JK Rockhill, M Mrugala, AM Spence, I Kalet, K Hendrickson, ... Physics in Medicine & Biology 55 (12), 3271, 2010 | 344 | 2010 |
| Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology LB Nabors, J Portnow, M Ahluwalia, J Baehring, H Brem, S Brem, ... Journal of the National Comprehensive Cancer Network 18 (11), 1537-1570, 2020 | 333 | 2020 |
| Advances and challenges in the treatment of glioblastoma: a clinician’s perspective MM Mrugala Discovery medicine 15 (83), 221-230, 2013 | 276 | 2013 |
| Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model CH Wang, JK Rockhill, M Mrugala, DL Peacock, A Lai, K Jusenius, ... Cancer research 69 (23), 9133-9140, 2009 | 262 | 2009 |
| Intracranial meningiomas: an overview of diagnosis and treatment J Rockhill, M Mrugala, MC Chamberlain Neurosurgical focus 23 (4), E1, 2007 | 252 | 2007 |
| NCCN guidelines insights: central nervous system cancers, version 1.2017 LB Nabors, J Portnow, M Ammirati, J Baehring, H Brem, N Butowski, ... Journal of the National Comprehensive Cancer Network 15 (11), 1331-1345, 2017 | 180 | 2017 |
| Mechanisms of disease: temozolomide and glioblastoma—look to the future MM Mrugala, MC Chamberlain Nature clinical practice Oncology 5 (8), 476-486, 2008 | 179 | 2008 |
| Central nervous system cancers LB Nabors, M Ammirati, PJ Bierman, H Brem, N Butowski, ... Journal of the National Comprehensive Cancer Network 11 (9), 1114-1151, 2013 | 171 | 2013 |
| Clinical practice experience with NovoTTF-100A™ system for glioblastoma: the Patient Registry Dataset (PRiDe) MM Mrugala, HH Engelhard, DD Tran, Y Kew, R Cavaliere, JL Villano, ... Seminars in oncology 41, S4-S13, 2014 | 149 | 2014 |
| Central nervous system cancers SS Brem, PJ Bierman, H Brem, N Butowski, MC Chamberlain, EA Chiocca, ... Journal of the National Comprehensive Cancer Network 9 (4), 352-400, 2011 | 142 | 2011 |
| Central nervous system cancers clinical practice guidelines in oncology SS Brem, PJ Bierman, P Black, DT Blumenthal, H Brem, MC Chamberlain, ... JNCCN Journal of the National Comprehensive Cancer Network 3 (5), 644-690, 2005 | 139 | 2005 |
| Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma D Corwin, C Holdsworth, RC Rockne, AD Trister, MM Mrugala, ... PloS one 8 (11), e79115, 2013 | 137 | 2013 |
| High-dose methotrexate for elderly patients with primary CNS lymphoma JJ Zhu, ER Gerstner, DA Engler, MM Mrugala, W Nugent, K Nierenberg, ... Neuro-oncology 11 (2), 211-215, 2009 | 136 | 2009 |
| Rhythmic multiunit neural activity in slices of hamster suprachiasmatic nucleus reflect prior photoperiod M Mrugala, P Zlomanczuk, A Jagota, WJ Schwartz American Journal of Physiology-Regulatory, Integrative and Comparative …, 2000 | 131 | 2000 |
| Peripheral and cranial nerve sheath tumors MM Mrugala, TT Batchelor, SR Plotkin Current opinion in neurology 18 (5), 604-610, 2005 | 129 | 2005 |
| Rindopepimut with bevacizumab for patients with relapsed EGFRvIII-expressing glioblastoma (ReACT): results of a double-blind randomized phase II trial DA Reardon, A Desjardins, JJ Vredenburgh, DM O'Rourke, DD Tran, ... Clinical Cancer Research 26 (7), 1586-1594, 2020 | 121 | 2020 |
| Extended survival of glioblastoma patients after chemoprotective HSC gene therapy JE Adair, BC Beard, GD Trobridge, T Neff, JK Rockhill, DL Silbergeld, ... Science translational medicine 4 (133), 133ra57-133ra57, 2012 | 120 | 2012 |
